Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug
- Posted on October 3, 2024
- By Financial Express
- 4 Views
Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug
Additionally, Lenacapavir is currently under investigation for the prevention of HIV (PrEP) which is yet to be approved globally.
